广告
加载中

美妆“金饭碗” 正在被AI蒸馏

张从容 2026-05-18 16:48
张从容 2026/05/18 16:48

邦小白快读

EN
全文速览

本文核心讲人工智能已经进入美妆行业上游研发环节,给美妆研发带来了颠覆性变化,核心干货如下:

1. 传统美妆研发依赖人工实验筛选,靠碰运气出结果,耗时几个月甚至几年,成本高昂,AI通过总结数据规律,能定向搜索最优解,目前已经能将研发周期缩短约一半,大幅降低试错成本。

2. AI已经实现落地应用,珀莱雅、环亚集团、知美集团等品牌都已经将AI研发的成分应用到自家明星产品中,多家AI研发企业也获得了上亿元融资,资本十分看好该赛道。

3. 普通研发从业者不需要过度焦虑就业,不需要担心AI抢饭碗,只要把AI当做工具和伙伴,学会和AI相处,成为AI native就能适应新的工作模式。

AI介入美妆上游研发,给美妆品牌的产品研发和竞争力提升带来了全新机遇,核心干货如下:

1. 产品研发端,AI能帮品牌提前完成成分虚拟筛选,把传统CRO广撒网的筛选模式变成精准捕捞,能大幅降低千万级的研发成本,将研发周期缩短一半,更快响应市场对成分迭代升级的需求。

2. 已经有多个成熟落地案例,珀莱雅用AI完成环肽163的靶点筛选应用到红宝石系列,知美集团用AI锁定A醇的温和替代成分补骨脂酚,成功打造出了明星单品。

3. 当前头部品牌对原料的核心诉求是差异化、独家性和安全性,AI能快速匹配该需求,目前欧莱雅、资生堂等国际头部品牌都已经悄悄布局AI研发,国货品牌也可以抓住这个机会突破创新瓶颈,实现弯道超车。

AI进入美妆上游研发,给美妆卖家带来了新的增长机会,同时也有需要注意的风险,核心干货如下:

1. 机会层面,当前消费端对美妆成分的迭代速度要求越来越高,消费者也更偏好功效明确、有创新成分的产品,AI能帮助卖家快速推出符合需求的差异化新品,抢占市场份额。

2. 可对接的合作模式已经成熟,卖家可以和AI研发企业、原料厂、CRO机构合作,先用AI筛选高潜力成分,再做后续验证,能大幅降低试错成本,不少国货品牌已经跑出了成功案例。

3. 需要注意的风险,目前AI落地还存在明显瓶颈,后端湿实验验证依然依赖人工,行业内没有企业愿意共享核心研发数据,全新原料备案需要一年以上周期,不要盲目跟风概念炒作,要理清落地链路再布局。

AI给美妆原料工厂带来了新的竞争机遇和数字化转型方向,核心干货如下:

1. 产品研发设计层面,传统原料研发靠碰运气获得优质序列,不确定性高、升级难度大,AI可以依托过往数据总结规律,实现理性定向研发,大幅缩短开发周期,降低试错成本。美尚洁生物就是靠AI从行业龙头的夹缝中突围,还获得了数千万元融资。

2. 商业机会层面,AI研发的差异化原料深受头部品牌青睐,已经有企业从只提供研发服务,转型为研发+自产原料供应,拓展了盈利渠道和业务边界。

3. 转型启示,工厂可以主动对接AI服务商,搭建专属的AI研发平台,积累自身研发的正负向实验数据持续优化模型,核心团队也需要主动学习AI相关知识,适配新的研发模式。

AI赋能美妆研发给各类美妆相关服务商带来了新的发展机遇和调整方向,核心干货如下:

1. 行业发展趋势,AI正在重构美妆研发的产业分工,AI已经从下游客服营销环节向上游研发渗透,原来AI服务商、原料厂、CRO的边界正在模糊,新的产业分工正在逐步形成。

2. 客户核心痛点,美妆品牌的核心痛点是传统研发成本高、周期长,难以推出符合要求的差异化创新原料,客户需要降本提速,同时保证原料的安全性和合规性。

3. 解决方案和发展方向,传统CRO机构可以主动对接AI技术升级原有服务,AI服务商可以拓展业务边界,从只卖研发服务延伸到研发+原料供应,还可以探索和自动化实验室绑定,解决后端湿实验验证滞后的痛点,盈利模式也可以从按项目收费转型为按销售分佣,提升盈利空间。

AI美妆研发的浪潮给平台带来了新的发展机遇,也需要注意规避相应风向,核心干货如下:

1. 当前行业对AI美妆研发的需求旺盛,越来越多美妆品牌、原料厂、AI研发企业都在布局该赛道,需要平台对接上下游资源,平台可以围绕AI美妆研发打造新的服务板块,吸引创新主体入驻。

2. 最新行业动态显示,资本已经高度关注AI for Science类美妆相关企业,多家企业获得了大额融资,国际头部品牌和国货头部品牌都已经落地了AI研发项目,平台可以针对性开展招商,吸引AI研发、AI原料这类创新企业入驻,丰富平台的品类和业态。

3. 需要规避的风向,目前AI美妆研发落地还存在很多瓶颈,存在云端热物理端冷的问题,核心研发数据不共享,新原料备案周期长,部分项目存在概念化炒作的问题,平台引入相关企业的时候要核实落地进展,规避虚假炒作带来的风险。

AI渗透美妆上游研发是产业界的全新动向,出现了很多新问题新商业模式值得研究,核心干货如下:

1. 产业新动向,AI此前主要影响美妆行业的客服、设计、营销等下游环节,现在已经进入门槛更高的上游研发环节,重构了美妆研发逻辑,从传统广撒网碰运气的模式变为精准理性设计,多家头部品牌已经布局,AI相关企业也获得了资本的大量投入,行业即将迎来大洗牌。

2. 产业新问题,目前AI落地存在云端热物理端冷的错配,后端湿实验验证依然是瓶颈,行业内企业不愿共享核心研发数据,中小主体没有足够数据训练AI模型,全新原料备案周期长达一年以上,这些问题都制约了行业创新。

3. 新商业模式,AI服务商已经探索出从卖研发服务到“研发+自产原料”的转型路径,盈利模式也从按项目收费转向按销售分佣,产业原有各类主体的边界逐步模糊,新的分工体系正在形成,值得持续跟踪研究。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article explores how artificial intelligence has penetrated upstream R&D in the beauty industry, bringing disruptive changes to product development. Key takeaways are as follows:

1. Traditional beauty R&D relies on manual experimental screening, delivering results largely by chance, taking months or even years at high cost. By summarizing patterns in historical data, AI can conduct targeted searches for optimal solutions, cutting R&D cycles roughly in half and substantially reducing trial-and-error costs to date.

2. AI is already being applied in real-world operations: brands including Proya, Huanya Group and Zhimei Group have integrated AI-developed ingredients into their star products. Multiple AI-powered beauty R&D startups have also raised hundreds of millions of yuan in funding, reflecting strong investor confidence in this segment.

3. Ordinary R&D practitioners do not need to be overly anxious about job displacement. By treating AI as a tool and collaborator, learning to work with the technology and becoming "AI-native," they can adapt to the new working model.

AI’s entry into upstream beauty R&D has created unprecedented opportunities for beauty brands to accelerate product development and boost competitiveness. Key insights are as follows:

1. For product R&D, AI enables brands to complete virtual screening of ingredients in advance, transforming the traditional broad-net screening model of contract research organizations (CROs) into a targeted approach. This can cut hundreds of millions of yuan in R&D costs, halve development cycles, and allow brands to respond faster to market demand for ingredient upgrades.

2. There are already multiple proven successful use cases: Proya used AI to complete target screening for Cyclopeptide-163, which is now used in its popular Ruby series; Zhimei Group used AI to identify bakuchiol, a gentle alternative to retinol, and successfully built it into a top-selling product.

3. Today, core demands of leading beauty brands for raw materials are differentiation, exclusivity and safety, all of which AI can match quickly. International giants including L’Oréal and Shiseido have already quietly built out AI R&D capabilities, and Chinese domestic brands can also leverage this opportunity to break through innovation bottlenecks and achieve an overtake on the curve.

AI’s penetration into upstream beauty R&D brings new growth opportunities for beauty sellers, along with notable risks to watch for. Key takeaways are as follows:

1. On the opportunity side, consumers now demand faster ingredient iteration for beauty products, and increasingly favor products with clearly defined efficacy and innovative ingredients. AI enables sellers to quickly launch differentiated new products that meet market demand and capture greater market share.

2. Mature cooperation models are already available: sellers can partner with AI R&D firms, raw material factories and CROs to screen high-potential ingredients via AI first before conducting downstream validation, which greatly cuts trial-and-error costs. Multiple Chinese domestic brands have already posted successful results from this approach.

3. Key risks to note: AI implementation still faces clear bottlenecks. Back-end wet-lab validation still relies heavily on manual work, no industry player is willing to share core R&D data, and regulatory approval for entirely new raw materials takes more than one year. Sellers should avoid jumping on the bandwagon of concept hype, and map out a clear implementation path before committing resources.

AI has brought new competitive opportunities and a clear digital transformation direction for beauty raw material factories. Key insights are as follows:

1. For R&D and product design, traditional raw material development relies on chance to identify high-quality sequences, resulting in high uncertainty and slow iteration. AI can leverage historical data to identify patterns, enabling rational, targeted R&D that greatly shortens development cycles and cuts trial-and-error costs. For example, Meishangjie Biotech has used AI to break out from the shadow of industry giants and raised tens of millions of yuan in funding.

2. For business opportunities, differentiated raw materials developed via AI are highly sought after by leading brands. Some players have already transformed from offering only R&D services to a combined "R&D + in-house raw material supply" model, expanding both revenue streams and business boundaries.

3. Key takeaways for transformation: factories can proactively partner with AI service providers to build dedicated AI R&D platforms, accumulate positive and negative experimental data from their own work to continuously optimize models, and core teams need to proactively learn AI-related knowledge to adapt to the new R&D model.

AI-powered beauty R&D brings new development opportunities and strategic adjustment directions for all types of beauty-related service providers. Key insights are as follows:

1. Industry trend: AI is reshaping industrial division of labor in beauty R&D. It has expanded from downstream customer service and marketing to upstream R&D, and the traditional boundaries between AI service providers, raw material factories and CROs are blurring, with a new industrial structure gradually emerging.

2. Core customer pain points: For beauty brands, the biggest pain points are high costs and long cycles of traditional R&D, which make it hard to deliver the differentiated innovative ingredients the market demands. Brands need to cut costs and speed up development while ensuring the safety and compliance of raw materials.

3. Solutions and development directions: Traditional CROs can proactively integrate AI technology to upgrade their existing services. AI service providers can expand their business boundaries, moving from pure R&D service offerings to combined R&D and raw material supply. They can also explore partnerships with automated laboratories to resolve the pain point of delayed back-end wet-lab validation. They can also transform their revenue model from project-based fixed fees to sales-based royalties, boosting profit margins.

The wave of AI-powered beauty R&D brings new development opportunities for platforms, alongside risks that need to be managed. Key takeaways are as follows:

1. There is currently strong industry demand for AI-powered beauty R&D, with a growing number of beauty brands, raw material factories and AI R&D firms building out capabilities in this space, all requiring platforms to connect upstream and downstream resources. Platforms can build new service segments focused on AI beauty R&D to attract innovative market participants to join.

2. Latest industry developments show that capital is already highly focused on AI for Science beauty startups, with multiple players raising large funding rounds. Both leading international and Chinese domestic beauty brands have already launched AI R&D projects. Platforms can carry out targeted investment promotion to attract innovative AI R&D and AI-enabled raw material companies, enriching the platform’s product categories and business ecosystem.

3. Risks to avoid: AI beauty R&D still faces many implementation bottlenecks, including a mismatch between overhyped cloud-based solutions and limited real-world physical testing, lack of core R&D data sharing, long new raw material approval cycles, and widespread concept hype. Platforms should verify implementation progress when onboarding related companies to avoid risks from false marketing claims.

The penetration of AI into upstream beauty R&D is a new industry development, with many new problems and business models that merit further research. Key insights are as follows:

1. New industry trends: Previously, AI mainly impacted downstream links of the beauty industry such as customer service, design and marketing; it has now moved into the higher-barrier upstream R&D segment, restructuring the core logic of beauty development. The traditional broad-net, chance-based model is being replaced by precise, rational design. Multiple leading brands have already built out AI R&D capabilities, AI-focused companies have received substantial capital inflows, and the industry is poised for a major shakeout.

2. Unresolved industry challenges: AI implementation currently faces a mismatch between overheated cloud-based development and underdeveloped real-world physical testing, with back-end wet-lab validation remaining a major bottleneck. Industry players are unwilling to share core R&D data, small and medium-sized market participants lack sufficient data to train AI models, and new raw material approval takes more than one year—all of these factors constrain industry innovation.

3. Emerging business models: AI service providers have already explored a transformation path from pure R&D service offerings to a combined "R&D + in-house raw material supply" model, shifting from project-based fixed fees to sales-based royalties. The boundaries between traditional industry players are gradually blurring, and a new division of labor is taking shape—all of which require continued tracking and research.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

欧莱雅珀莱雅都在悄悄投入

文丨张从容

编辑丨董金鹏

【亿邦原创】在美妆行业,人们对AI的兴奋与焦虑,正在向上游研发环节传导。

张凤(化名)博士毕业,在一家美妆原料公司做研发。过去,这样的岗位需要积累几年经验,经历从研发到产品上市。她所从事的多肽序列设计与优化,依赖合成与实验筛选,每次耗时数月甚至数年。

然而现在,AI正在大幅提升美妆研发的速度,许多颇为惊人。张凤曾设计了一套多肽序列,一边做实验验证,一边用AI预测。结果,实验与预测一致,真的失败了。

你可能并不知道,AI帮珀莱雅完成环肽163的分子构象和靶点筛选,将应用至红宝石系列产品;AI帮环亚集团筛选稀有人参皂苷CMx,应用至美肤宝反重力面霜2.0;知美集团则用AI锁定A醇的温和替代成分补骨脂酚,应用至AB LAB的明星单品“女巫眼霜”。

与此同时,一批AI for Science公司正在成为资本关注的重点。2026年3月,天鹜科技完成超2亿元A+轮融资;MetaNovas连续完成A+、A++两轮融资。

如果说淘汰客服、设计和营销等是美妆行业掀起的集体“瘦身”,那么AI“入侵”门槛更高的科研环节,无疑是行业大洗牌的前兆。它会带来哪些机会?又会抢走谁的饭碗?

研发岗位正在被蒸馏,开发周期缩短约一半

社交媒体上,有一类视频很火,研究生博士生对着实验台磕头,祈求实验得到理想结果。“真的就是拜大神,运气好就能做出来一条非常不错的(序列),”美尚洁生物CEO赵铧说,“然后好,就这样!不要动!把序列记下来,拿这个去做。”

在他看来,这种行为的背后,是传统研发模式的不确定性——靠“碰运气”得到一组优质序列,一旦成功就立刻锁定条件、固定参数,基于该结果推进后续研究。

而原因在于,人类不知道好结果是怎么来的,所以升级迭代时,不知道往哪儿改。同样,搞清楚为什么错也很难,所以返工时要回到设计环节,花费大量时间探索下一步如何调整。

图片

AI则偏向理性设计,在现有数据指引下,总结人类看不到的规律,并有方向地搜索最优解。随着数据的累积、人类这个“考官”不断为其“批改”,AI的准确率会越来越高。

赵铧曾在爱茉莉太平洋集团担任电商销售总监,操盘国内10亿规模业务,2018年成立美尚洁生物,目前在江苏省生物科技协会担任常务理事。美尚洁生物是一家重组胶原蛋白原料工厂,从巨子生物、锦波生物等行业龙头的夹缝中杀出来,靠的正是AI。

以过往累积的数据为基础,美尚洁生物与AI服务商合作,搭建了AI重组蛋白定向设计与深度研发平台,并通过湿实验不断验证AI的预测结果,用真实反馈持续优化模型。为了高效对接AI服务商,赵铧本人正在悉尼科技大学攻读AI科技硕士学位。

2025年10月,美尚洁生物对外宣称,完成数千万人民币A+轮融资。此后不久,天鹜科技、MetaNovas等也相继获得资本青睐。

MetaNovas,成立于2021年,美妆原料研发企业,可根据预设需求,用AI设计出兼顾功效和落地要求的分子。2025年11月,MetaNovas自主研发的AI设计多肽原料“寡肽293”,完成医疗器械主文档备案。

除文献和专利,以及与科研机构合作的数据,MetaNovas的AI研发还用到公司内部数据。AI团队设计分子,交给生物团队验证,并反馈数据结果,将正面和负面样本均投喂给AI,让AI再学习生产。生物团队用知识图谱设计或筛选成分,再做功效验证。

MetaNovas招了一批生物信息学背景的人,主要处理输入的数据和现有知识,得出可指导研发的结论。数据来源可自产自销,AI有自主思考和判断能力。CEO王梅杰称,这种工作的价值,在内部已被AI蒸馏。

天鹜科技,成立于2021年,以自研蛋白质设计大模型起家。大模型的工作逻辑是:在海量数据上预训练,让模型学会蛋白质的“底层规则”,再结合少量湿实验数据进行微调。这样一来,模型能精准预测哪些突变点位能提升哪些特定功能,比如耐碱性或热稳定性,实现高效的蛋白质定向进化。

实际上,有研发人员用ChatGPT预测实验结果,发现有时准确,有时明显错误。但把积累的实验结果喂给AI,再做预测,结果会更准确。他们希望人类找到几十个候选序列后,先用AI筛出来几个最有可能成功的,再拿去做实验验证,降低试错成本。

图片

与此同时,有研发人员明显感知到,市场对成分迭代速度的要求也越来越快。知情者告诉亿邦动力,在AI辅助下,某护肤品牌即将落地的新一代成分,研发周期较以前缩短约一半。

欧莱雅资生堂悄悄入局,国货品牌AI似无战事

王梅杰曾在英伟达工作,下班后开车去海边吹风,最开始觉得惬意,后来隐隐感觉有点浪费人生。“我可能更加喜欢一种比较紧张的生活和工作节奏吧。”

2021年,王梅杰回国创办MetaNovas。2023年,MetaNovas斩获欧莱雅Big Bang美妆科技创造营冠军,才开始接触美妆客户。如今,公司的美妆客户占比过半。

MetaNovas设计出的原料,已经添加进部分品牌的产品。王梅杰称,包括美妆在内的快消品客户,对原料的主要诉求在于差异化、独家和安全,头部公司尤甚。服务大客户的经验,让MetaNovas的AI生意逐步成熟。2025年,MetaNovas成立工厂,从卖研发向卖研发+原料过渡。

品牌接入AI,最直接的落点之一是在“成分筛选”环节。过去,这项工作主要外包给CRO(合同研究组织)——品牌提出需求,CRO负责筛选、测试候选分子,按工时或按分子数量收费。

比如拜尔斯道夫旗下的提安明多630,从5万多个分子中层层筛选,最终开发成本高达千万级;同属美白赛道的377,其成本也达到了千万量级。

CRO的筛选逻辑是“广撒网”:把所有可能相关的分子都合成出来、测一遍。这种模式虽然有效,但成本高昂、周期漫长。AI介入后,逻辑变成了“精准捕捞”——在交给CRO之前,品牌先用AI模型做一轮虚拟筛选。

据第十四章创始人梅鹤祥介绍,可以先让AI用Lipinski规则和ADMET规则,筛选出符合要求的分子,再交给CRO研究。他现场演示了该AI模型对多个热门原料的检测结果。梅鹤祥称,这样能降低化妆品企业的CRO研发预算。

据了解,因天花板太低,有AI for Science的服务商正有意减少CRO业务,逐步转型为按销售分佣。同时,部分CRO机构也在与AI接轨。

欧易生物,一家CRO机构,过去主要服务医药行业,约两年前涉足化妆品领域,目前已与资生堂、欧莱雅、雅诗兰黛等品牌合作。其研发与美丽健康创新中心负责人彭章晓,过去主要研究中医药领域。他曾参加华师大“美丽健康CTO”班,意外发现众多化妆品企业也在做组学研究,便带领团队向该方向拓展。

欧易生物主要用AI辅助品牌解析原料“为什么有效”,如可视化地呈现作用靶点、透皮吸收、物质基础。品牌可以拿这些发论文、申请专利,在B端做科学传播。

AI for Science服务商、原料厂、CRO机构……在AI的加持下,各方的边界正在模糊,新的分工正在形成。AI把筛选的“漏斗”上半段变窄,但下半段的湿实验验证——细胞、动物、人体测试——似乎依然是瓶颈。

除了少部分尝鲜的,对于这场即将到来的风暴,许多人还处在焦虑和探索之中。3月中旬,王梅杰参加化妆品活动,没有人探讨已经爆火的OpenClaw。“当时连李诞都在教你怎么用小龙虾了!”她说。

跟就业一毛钱关系没有,研发与应用为何冰火两重天

知美集团CEO kami是AI博士出身,创业初期就开始尝试将AI和企业相结合,早在2014年就开始做基于NLP的市场趋势分析。

他观察到,今年3月底以来的“龙虾热”,也在美妆行业掀起一股AI浪潮,老板们开始讨论OpenClaw等AI工具,都在焦虑如何用AI用进业务、用Agent处理实际问题,而落地则没有想象的那么一帆风顺。

AI研发飞速向前,但美妆品牌的需求却相对有限。行业人士称,云端发展得很快,物理端还是没有跟上。

以蛋白质设计为例:AI完成设计只需几小时甚至几天,但后续的湿实验验证却需要几十人耗费几个月乃至几年。而且,人工手动操作难以精确控制各种实验条件,容易导致实验失败。即便在失败后进行复盘,依然高度依赖人工介入,凭经验摸索调整,才能开启下一轮实验。

4月,天鹜科技推出支持自然语言对话的蛋白质设计智能体MatwingsVenus™(晓鹜™),将Agent与自动化实验室绑定,这一突破让AI从云端向物理端有所拓展。

图片

在需求端,美妆品牌不仅需要原料具备创新性,也希望原料安全、迅速地落地。kami认为,安全与有效并不矛盾,这也是美妆品牌人必须要坚守的底线。

在美妆行业,老牌企业固守于优势成分,新锐企业则追逐热门成分,创新成为了一种瓶颈。知美集团的AI研发重点,是将AI制药领域的药物研发逻辑应用到化妆品成分挖掘中,重点在筛选已备案的原料。

例如应用于AB LAB女巫眼霜中的补骨脂酚,就是AI从分子结构到靶点再到表征的多重分析后给出的选择:AI发现其与A醇功能相似,但效果好、副作用弱,并且海外已有护肤应用案例。

一款新原料的应用,除了安全性,另一个影响因素是备案时间——经历长达1年以上的备案时间。有行业人士解释称,设计自然界不存在的成分,需要经历较长的备案周期。

在这种情况下,品牌训练研发专用AI,可能陷入“巧妇难为无米之炊”的困境。数据是AI燃料,但没有企业愿意分享自己的核心数据。虽然行业专利是公开的,但企业不会公开研究过程中的序列和实验条件。

更致命的是,部分企业没有前端研发数据,直接从大学或研究机构购买核心序列,然后做发酵、提取、生产,却没有数据说明“为什么选这个序列”“试过哪些其他序列”“失败的原因是什么”。

因其学术背景,kami被国内多所985高校聘为产业研究生导师。课上,有学生很焦虑:当下AI迭代速度太快,想知道AI对未来就业到底有什么影响、该如何关注AI。他的回答是:把AI当工具,学会再多都会过时,且与未来就业几乎“一毛钱关系没有”。真正重要的是把AI当伙伴,学会与AI的相处模式,让自己成为AI native,问题也就迎刃而解。

亿邦持续追踪报道该情报,如想了解更多与本文相关信息,请扫码关注作者微信。

文章来源:亿邦动力

广告
微信
朋友圈

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0